MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis (Q34212162)

31 July 2017

title

MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis (English)

1 reference

intraepithelial neoplasia

31 July 2017

0 references

1 reference

1 reference

1 reference

Katia R M Leite

1 reference

31 July 2017

Alberto Tomiyama

1 reference

31 July 2017

Sabrina T Reis

1 reference

31 July 2017

Juliana M Sousa-Canavez

1 reference

31 July 2017

Adriana Sañudo

1 reference

31 July 2017

Luiz H Camara-Lopes

1 reference

31 July 2017

Miguel Srougi

1 reference

31 July 2017

publication date

30 August 2011

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

796-801

1 reference

Genetic alterations during colorectal-tumor development

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Molecular biology of prostatic intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Role of the TMPRSS2-ERG gene fusion in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNAs: small RNAs with a big role in gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Oncomirs - microRNAs with a role in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

A microRNA expression signature of human solid tumors defines cancer gene targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNA expression profiling in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNA expression profiles classify human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Widespread deregulation of microRNA expression in human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Loss of mir-146a function in hormone-refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Suppression of non-small cell lung tumor development by the let-7 microRNA family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The let-7 microRNA reduces tumor growth in mouse models of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

RAS is regulated by the let-7 microRNA family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

The let-7 microRNA represses cell proliferation pathways in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNA-143 as a tumor suppressor for bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.002

10.1016/J.UROLONC.2011.07.002

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference